Found: 5
Select item for more details and to access through your institution.
Relaxation of mitochondrial hyperfusion in the diabetic retina via N6-furfuryladenosine confers neuroprotection regardless of glycaemic status.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45387-9
- By:
- Publication type:
- Article
Targeting brain tumours: apoferritin nanocage for delivery of novel analogues of temozolomide.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. 4, doi. 10.1093/neuonc/noz167.015
- By:
- Publication type:
- Article
Mitophagy‐reporter Muller cell line (MQ‐MG2) as a novel platform for ocular drug discovery.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
One therapy to protect them all: Controlling diabetic eye disease in anterior and posterior segment via mitophagy‐activating drugs.
- Published in:
- Acta Ophthalmologica (1755375X), 2024, v. 102, p. N.PAG, doi. 10.1111/aos.15830
- By:
- Publication type:
- Article
PINK1‐mitophagy activator (PA‐01) overcomes mitochondrial hyperfusion conferring retinal neuroprotection in type‐1 diabetes.
- Published in:
- Acta Ophthalmologica (1755375X), 2024, v. 102, p. N.PAG, doi. 10.1111/aos.15834
- By:
- Publication type:
- Article